INNT vs. SCPS, VAXX, CALA, CMRA, ARDS, STAB, AMPE, CLVR, MTEM, and ONCSQ
Should you be buying Innovate Biopharmaceuticals stock or one of its competitors? The main competitors of Innovate Biopharmaceuticals include Scopus BioPharma (SCPS), Vaxxinity (VAXX), Calithera Biosciences (CALA), Comera Life Sciences (CMRA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Ampio Pharmaceuticals (AMPE), Clever Leaves (CLVR), Molecular Templates (MTEM), and OncoSec Medical (ONCSQ). These companies are all part of the "medical" sector.
Innovate Biopharmaceuticals vs. Its Competitors
Scopus BioPharma (NASDAQ:SCPS) and Innovate Biopharmaceuticals (NASDAQ:INNT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, community ranking, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.
5.9% of Innovate Biopharmaceuticals shares are held by institutional investors. 5.1% of Scopus BioPharma shares are held by insiders. Comparatively, 7.9% of Innovate Biopharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Scopus BioPharma has a beta of -0.23, suggesting that its share price is 123% less volatile than the S&P 500. Comparatively, Innovate Biopharmaceuticals has a beta of -0.39, suggesting that its share price is 139% less volatile than the S&P 500.
Innovate Biopharmaceuticals received 201 more outperform votes than Scopus BioPharma when rated by MarketBeat users. However, 100.00% of users gave Scopus BioPharma an outperform vote while only 65.48% of users gave Innovate Biopharmaceuticals an outperform vote.
In the previous week, Innovate Biopharmaceuticals had 2 more articles in the media than Scopus BioPharma. MarketBeat recorded 2 mentions for Innovate Biopharmaceuticals and 0 mentions for Scopus BioPharma. Scopus BioPharma's average media sentiment score of 0.00 equaled Innovate Biopharmaceuticals'average media sentiment score.
Summary
Scopus BioPharma and Innovate Biopharmaceuticals tied by winning 4 of the 8 factors compared between the two stocks.
Get Innovate Biopharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for INNT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding INNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Innovate Biopharmaceuticals Competitors List
Related Companies and Tools
This page (NASDAQ:INNT) was last updated on 6/13/2025 by MarketBeat.com Staff
Buy INNT Stock Free INNT Stock Alerts